Related Experiment Video
Updated: Nov 3, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
The Impact of Chromium Supplementation on Blood Pressure: A Systematic Review and Dose-Response Meta‑Analysis of
Abolfazl Lari1, Somaye Fatahi1, Mohammad Hassan Sohouli2,3
1Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran, Iran.
Insights
Chromium supplementation significantly lowers blood pressure, reducing both systolic and diastolic measures. Specific forms like chromium yeast and brewer's yeast showed greater effects on systolic blood pressure.
Area of Science:
- Nutritional Science
- Cardiovascular Health
- Evidence-Based Medicine
Background:
- Conflicting results exist regarding chromium supplementation's effect on blood pressure.
- Previous interventional studies show varied outcomes on blood pressure management.
Purpose of the Study:
- To conduct a systematic review and meta-analysis on chromium supplementation's impact on blood pressure.
- To synthesize evidence from randomized clinical trials (RCTs) on chromium and blood pressure.
Main Methods:
- Systematic search of five databases (Web of Science, Scopus, Embase, Google Scholar, PubMed) up to March 2020.
- Inclusion of 11 randomized clinical trials (RCTs) involving 637 participants.
- Meta-analysis of RCTs assessing chromium's effect on systolic blood pressure (SBP) and diastolic blood pressure (DBP).
Main Results:
- Chromium supplementation significantly reduced both SBP (WMD -2.51 mmHg) and DBP (WMD -1.04 mmHg).
- Subgroup analysis indicated greater SBP reduction with chromium yeast and brewer's yeast.
- Significant SBP reduction was observed in diabetic patients with chronic heart disease (CHD); dosage influenced SBP changes.
Conclusions:
- Chromium supplementation effectively decreases both systolic and diastolic blood pressure.
- Chromium yeast and brewer's yeast forms appear more effective for SBP reduction.
- Further large-scale RCTs are recommended to validate these findings on blood pressure management.
Introduction:
Potential effects of chromium supplementation on blood pressure (BP) have been examined in several interventional studies. Nevertheless, findings in this context are controversial.
Aim:
Therefore, the current systematic review and meta-analysis aimed to comprehensively assess the impact of chromium supplementation on BP.
Methods:
Five online databases including Web of Science, Scopus, Embase, Google Scholar, and PubMed were systematically searched from inception to March 2020. We included all randomized clinical trials (RCTs) evaluating the effects of chromium supplementation on systolic blood pressure (SBP) and/or diastolic blood pressure (DBP) in humans.
Results:
The random-effects meta-analysis of 11 eligible RCTs with 637 participants demonstrated the significant decline in both SBP (WMD - 2.51 mmHg; 95% CI - 4.97 to - 0.05, p = 0.04) and DBP (WMD - 1.04 mmHg; 95% CI - 1.96 to - 0.12, p = 0.026) following supplementation with chromium. In subgroup analysis, studies that were administered chromium yeast and brewer's yeast, showed greater decrease in SBP. Also, in stratification based on participants' health status, significant reduction in SBP only was seen in diabetic patients with chronic heart disease (CHD). Nonlinear dose-response analysis revealed a significant influence of chromium dosage on SBP changes.
Conclusion:
The current meta-analysis, indicated that supplementation with chromium significantly decrease SBP and DBP. In subgroup analysis, administration of chromium yeast and brewer's yeast resulted in greater reduction in SBP. Further large-scale RCTs with better design are needed to confirm these findings.
More Related Videos
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
08:01A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management
Hypertension and Regulation of Blood Pressure
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...